nedaplatin has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z; Han, A; He, G; Li, Y; Pan, J; Wang, W; Yang, K; Zhang, X | 1 |
| Jiang, L; Li, M; Liang, J; Liu, B; Liu, J; Lu, C; Ma, S; Ren, H; Zhang, Q; Zhu, R | 1 |
| Chen, XB; Deng, WY; Han, LL; Li, N; Luo, SX; Zhou, MQ | 1 |
3 other study(ies) available for nedaplatin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study.
Topics: Bronchial Arteries; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoembolization, Therapeutic; Epithelial Cells; Humans; Liver Neoplasms; Lung Neoplasms; Polyvinyl Alcohol; Retrospective Studies; Treatment Outcome | 2023 |
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Flavonols; Humans; Liver Neoplasms; Organoplatinum Compounds; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2015 |
[The study of anti-tumor effect of Tetrandrine combined with Nedaplatin on human liver cancer cell line 7402].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Humans; Inhibitory Concentration 50; Liver Neoplasms; Menispermaceae; Organoplatinum Compounds; Plants, Medicinal; Proto-Oncogene Proteins c-bcl-2 | 2008 |